January 23, 2026
From the Chairman
50
01
Today, we’re taking our brand to the next level so we can strengthen our commitment to scientists, innovators, and C-suite leaders who trust us for science-driven insights for faster and smarter manufacturing of safe, effective, successful therapies.
January 20, 2026
Manufacturing
50
01
Industry experts discuss the standout packaging trends from 2025 that will influence the industry’s future.
January 16, 2026
Outsourcing
50
01
Contract development and manufacturing organizations offer specialized services to help sponsor companies develop drug products that better serve the unique needs of patients.
January 16, 2026
50
01
Ensuring quality, sterility, and regulatory compliance are essential when choosing analytical methods.
January 16, 2026
Ask the Expert
50
01
The development, quality, and procurement teams should work together to determine which materials and suppliers are needed, says Jane Zhang, Co-Founder & Co-CEO, ETCH Sourcing, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company.
January 14, 2026
Special Report
50
01
Survey results show a shift in pharma industry sentiment from optimism to caution as rising insecurity offsets high satisfaction and intellectual engagement.
January 14, 2026
Development
50
01
AI and machine learning are helping pharmaceutical scientists more efficiently develop innovative and novel treatments for a range of disease areas.
January 13, 2026
Cover Story
50
01
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
January 13, 2026
Quality/Regulations
50
01
To combat growth and pricing pressures, companies are auditing their supply chains and API material providers.